Andrew E. Hendifar, MD (Medical Oncology)Co-Director, Pancreas Oncology
Gastrointestinal and Neuroendocrine Oncology
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
8700 Beverly Boulevard, AC 1042C
Los Angeles, CA 90048
310-423-0709 (Christopher Morgan, new patient coordinator)
Dr. Hendifar is the primary investigator for several groundbreaking therapies, including radioimmunotherapy for neuroendocrine tumors. He is helping to develop the use of stromal agents and gene-targeted therapies in the treatment of neuroendocrine tumors. Dr. Hendifar’s research involves studying cachexia in his cancer patients. He has developed a treatment protocol in cancer cachexia that will increase understanding of this phenomenon. The goal is to develop new therapies for this condition.